Financial Reports Latest Updates Industry Maps Economic Calendar

Anika Therapeutics, Inc. (ANIK) Annual Reports

Q: Where can I read Anika Therapeutics, Inc. (ANIK) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

Anika Therapeutics, Inc. is listed on Nasdaq, classified by the SEC under Surgical & Medical Instruments & Apparatus (SIC 3841). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 12/31
SEC CIK： 898437 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Revenue	$32.6M	$28.2M	+15.6%
Operating income	$3.0M	$-4.2M	+170.7%
Net income	$3.3M	$-4.0M	+183.4%
EPS (diluted)	$0.24	$-0.28	+185.7%

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 32.6 mn Net income 3.31 mn

Show table：Income statement

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	40.1	14.5	13.9	14.7	11.7	16.1	18.5	18.4	14.4	19.6	14.8	22.6	14.5	20.8	17.8	21.3	14.3	26.3	22.1	23.3	15.5	22.9	23.7	30.9	22.3	26.6	25.8	28.7	23.4	33.5	27.2	29.4	21.3	30.6	26.8	27.0	24.7	30.4	29.7	29.8	35.4	30.7	31.7	32.7	34.3	38.1	39.5	35.8	36.7	39.7	40.3	39.6	37.9	44.3	41.5	43.0	40.5	41.9	38.8	-1.29	26.2	28.2	27.8	30.6	29.6	32.6
Gross profit	—	—	—	—	5.46	8.76	10.4	10.6	7.20	10.8	6.83	14.2	9.65	13.8	11.7	13.9	9.99	15.9	16.3	12.4	11.2	17.6	18.5	19.3	16.9	20.5	20.8	20.8	17.3	22.0	20.9	20.2	13.4	22.4	18.5	19.9	17.4	23.6	23.7	21.1	21.2	13.7	17.3	16.8	21.0	20.8	23.0	18.1	21.8	24.9	22.8	24.1	22.8	29.0	24.9	26.3	24.6	27.4	1.44	22.6	14.7	14.4	15.6	19.2	19.0	21.2
Operating income	5.59	1.80	2.08	2.48	0.56	3.68	4.82	4.92	3.06	6.13	2.73	7.79	5.01	9.40	7.77	10.4	23.9	15.2	10.3	12.1	5.50	12.4	13.1	17.1	10.7	13.5	13.7	12.7	8.01	17.7	10.3	9.73	-7.83	11.3	8.57	9.76	5.48	11.9	12.1	4.80	7.09	-9.54	-7.93	-17.9	1.26	9.18	1.30	-9.12	-3.55	-3.38	-5.80	-6.67	-12.6	-3.63	-7.67	-63.8	-5.06	0.16	-28.0	27.8	-4.28	-4.18	-3.23	0.65	-5.49	2.95
Net income	3.69	1.07	1.18	1.35	0.32	2.28	2.98	2.88	1.91	3.74	1.65	4.46	3.07	5.89	4.96	6.65	15.0	9.30	6.17	7.82	3.52	7.82	8.38	11.0	6.90	8.62	8.95	8.09	5.49	11.4	6.89	8.07	-6.69	10.1	7.60	7.72	4.51	9.44	9.20	4.05	5.79	-7.71	-6.41	-15.7	2.84	6.53	0.56	-5.79	-2.93	-2.84	-4.17	-4.91	-10.3	-2.74	-6.58	-63.0	-4.51	-0.09	-29.9	-21.9	-4.87	-3.97	-2.33	0.29	-5.06	3.31

Balance sheet

Quarterly · In mn (USD)

Total assets 183 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	—	—	—	56.3	—	57.5	58.6	64.1	64.0	69.6	68.4	77.4	78.7	86.5	95.0	94.6	113	120	129	139	146	156	168	176	148	155	161	170	177	193	199	206	208	191	196	203	210	190	224	234	161	221	202	177	173	178	166	169	165	168	168	170	160	152	157	163	159	155	136	114	103	99.3	102	103	93.6	99.2
Total assets	—	—	—	129	—	131	130	133	133	136	135	142	141	148	157	156	174	179	186	194	198	208	223	236	214	223	231	240	247	265	273	283	284	265	269	279	307	287	320	331	399	441	416	366	362	363	353	348	342	354	348	349	339	329	328	271	264	263	231	203	191	188	189	190	179	183
Current liabilities	—	—	—	19.4	—	17.4	15.1	14.5	12.9	15.2	12.2	14.4	10.7	11.7	10.4	9.28	7.71	7.32	6.43	5.97	6.16	7.96	13.2	17.3	10.9	10.5	7.59	8.80	10.2	13.4	11.7	13.1	14.1	12.5	9.31	11.3	11.6	10.4	11.2	16.3	26.2	27.9	31.1	36.9	47.0	41.4	28.8	29.8	27.0	29.4	26.4	27.9	28.7	23.5	28.1	31.1	28.5	26.1	25.5	23.3	17.9	16.1	19.1	21.9	21.0	22.1
Equity	82.1	—	—	85.2	—	91.1	92.8	94.8	98.3	101	103	109	113	119	128	136	157	162	170	178	182	191	200	211	195	204	215	223	230	244	253	263	264	247	255	264	269	251	282	288	294	288	284	272	277	287	290	287	286	286	285	286	278	274	270	212	209	210	180	154	148	148	147	143	134	137

Cash flow

Quarterly · In mn (USD)

Operating -0.68 mn Investing -1.28 mn Financing -0.7 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	3.09	0.78	3.31	3.77	1.29	-1.40	2.98	7.31	-1.69	5.22	2.20	4.81	6.07	3.56	7.53	8.01	13.6	6.72	4.90	14.8	3.98	10.9	8.91	15.3	7.68	-1.04	11.3	5.84	15.5	6.27	12.1	6.98	9.59	4.47	10.8	10.0	8.46	5.47	10.1	13.0	1.05	3.57	5.87	2.59	-2.43	4.29	2.06	4.47	-1.87	3.09	2.71	0.48	-3.62	-8.29	6.49	3.64	-0.13	-1.07	5.02	1.58	-0.13	-0.19	6.87	4.64	-4.85	-0.68
Investing	-20.2	-0.91	-0.81	-0.97	-0.08	-0.58	-0.3	-0.45	-0.22	-0.92	-0.15	-0.21	0.1	0.04	0.16	-0.55	-0.28	-0.4	-20.2	12.6	-6.01	-6.90	-4.38	-12.9	-1.67	-2.95	-2.49	0.35	-0.42	-7.99	-3.34	-0.72	0.21	7.26	-55.1	-2.58	-1.92	-1.52	2.10	41.0	-92.5	-2.30	6.73	16.8	1.73	-2.32	-1.29	-1.24	-1.33	-1.94	-1.69	-2.53	-1.39	-1.46	-0.74	-1.84	-1.81	-3.40	-1.82	-1.31	1.67	-0.54	-1.73	0.2	-1.24	-1.28
Financing	-1.64	-0.6	-0.4	-0.33	-0.37	-0.28	-0.4	-0.12	0.11	-0.36	-0.16	-0.35	0.76	-0.43	2.16	-8.19	5.50	-3.67	2.43	1.06	1.90	0.01	0.05	-0.03	-24.0	0.31	0.07	0.25	0.04	0.17	0.1	0	-1.22	-27.6	0	-0.05	-0.12	-30.0	21.7	0.28	-0.14	49.7	-25.2	-28.1	-0.45	0.59	-6.98	0.06	-0.86	-0.05	-4.61	0.67	-1.61	-4.94	-0.11	0.34	-2.27	-1.11	-3.99	-5.35	-5.44	0.18	-0.01	-5.28	-10.3	-0.7
Cash at period end	24.4	23.6	25.8	28.2	29.1	26.8	29.1	35.8	34.0	37.9	39.9	44.1	51.0	54.1	64.1	63.3	82.2	84.9	71.8	100	99.8	104	108	111	92.8	89.1	98.0	104	119	118	127	133	142	126	81.8	89.0	95.5	69.4	103	157	65.8	117	104	95.8	94.6	97.2	91.0	94.4	90.3	91.4	87.8	86.3	79.7	65.1	70.7	72.9	68.6	62.8	62.4	55.6	53.4	53.2	58.0	57.5	41.0	38.4

Profitability

Quarterly · %

Gross margin 65.2% Operating margin 9.1% Net margin 10.2%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Gross margin	—	—	—	—	46.5%	54.3%	56.1%	57.5%	50.1%	55.0%	46.3%	62.8%	66.6%	66.0%	65.6%	65.7%	69.6%	60.6%	73.7%	53.2%	72.2%	77.0%	78.1%	62.5%	75.6%	77.2%	80.6%	72.3%	74.0%	65.8%	77.0%	68.6%	63.1%	73.3%	69.1%	74.0%	70.4%	77.5%	79.7%	70.9%	59.9%	44.8%	54.7%	51.2%	61.2%	54.6%	58.2%	50.6%	59.4%	62.7%	56.6%	60.9%	60.2%	65.4%	60.2%	61.3%	60.8%	65.3%	3.7%	—	56.1%	50.9%	56.0%	62.6%	64.2%	65.2%
Operating margin	13.9%	12.4%	15.0%	16.8%	4.7%	22.8%	26.1%	26.6%	21.3%	31.3%	18.5%	34.5%	34.6%	45.1%	43.7%	49.1%	166.3%	57.9%	46.6%	52.0%	35.5%	54.3%	55.5%	55.2%	48.1%	50.7%	53.1%	44.4%	34.2%	53.0%	37.8%	33.1%	-36.8%	36.8%	32.0%	36.2%	22.2%	39.2%	40.6%	16.1%	20.0%	-31.1%	-25.0%	-54.9%	3.7%	24.1%	3.3%	-25.5%	-9.7%	-8.5%	-14.4%	-16.8%	-33.1%	-8.2%	-18.5%	-148.4%	-12.5%	0.4%	-72.3%	—	-16.4%	-14.8%	-11.6%	2.1%	-18.5%	9.1%
Net margin	9.2%	7.4%	8.5%	9.2%	2.8%	14.1%	16.1%	15.6%	13.3%	19.0%	11.1%	19.7%	21.2%	28.3%	27.9%	31.3%	104.7%	35.4%	28.0%	33.6%	22.6%	34.1%	35.4%	35.7%	30.9%	32.4%	34.7%	28.1%	23.5%	34.0%	25.3%	27.4%	-31.4%	33.0%	28.4%	28.6%	18.2%	31.0%	31.0%	13.6%	16.4%	-25.1%	-20.2%	-47.9%	8.3%	17.1%	1.4%	-16.2%	-8.0%	-7.2%	-10.4%	-12.4%	-27.3%	-6.2%	-15.9%	-146.6%	-11.1%	-0.2%	-77.2%	—	-18.6%	-14.1%	-8.4%	0.9%	-17.1%	10.2%

Returns & leverage

Quarterly · %

ROE -2.7% ROA -2.0%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	8.6%	—	5.6%	7.5%	9.4%	10.2%	12.0%	10.4%	11.5%	12.2%	13.7%	15.9%	16.8%	24.2%	25.5%	24.9%	24.4%	15.8%	14.3%	14.9%	15.8%	18.1%	17.7%	17.1%	15.0%	14.6%	15.1%	13.6%	13.1%	8.0%	7.5%	7.5%	7.1%	11.2%	11.8%	11.5%	9.8%	10.1%	4.2%	-1.5%	-8.6%	-9.4%	-4.4%	-2.0%	1.5%	-0.6%	-3.8%	-5.5%	-5.2%	-7.9%	-7.9%	-8.8%	-33.2%	-31.6%	-30.6%	-43.3%	-30.8%	-31.8%	-33.9%	-20.2%	-7.3%	-7.8%	-2.7%
ROA	—	—	—	5.7%	—	3.9%	5.3%	6.5%	7.5%	8.6%	7.7%	8.6%	9.4%	10.6%	12.6%	13.8%	20.6%	21.9%	21.7%	21.9%	14.4%	13.1%	13.5%	14.3%	16.6%	16.2%	15.6%	13.7%	13.5%	13.9%	12.6%	12.2%	7.4%	6.9%	7.0%	6.7%	10.1%	10.6%	10.5%	8.9%	8.1%	3.1%	-1.2%	-6.9%	-7.1%	-3.2%	-1.5%	1.2%	-0.5%	-3.1%	-4.5%	-4.3%	-6.5%	-6.5%	-7.3%	-26.7%	-25.5%	-25.1%	-34.9%	-23.8%	-25.0%	-26.9%	-15.7%	-5.5%	-6.0%	-2.0%

EPS

Quarterly · US$

EPS US$0.24

Show table：EPS

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	0.32	0.08	0.09	0.10	0.02	0.17	0.22	0.21	0.14	0.26	0.11	0.31	0.21	0.40	0.33	0.44	0.97	0.60	0.40	0.51	0.23	0.51	0.55	0.72	0.45	0.57	0.59	0.54	0.37	0.76	0.46	0.53	-0.46	0.68	0.53	0.54	0.31	0.67	0.64	0.28	0.40	-0.54	-0.45	-1.10	0.20	0.45	0.04	-0.40	-0.20	-0.20	-0.29	-0.34	-0.71	-0.19	-0.45	-4.30	-0.31	-0.01	-2.03	-1.49	-0.34	-0.28	-0.16	0.02	-0.37	0.24

Revenue & profit

Year-to-date · In mn (USD)

Revenue 62.2 mn Net income -1.75 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 183 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating -5.53 mn Investing -2.52 mn Financing -11.1 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Gross margin 64.7% Operating margin -4.1% Net margin -2.8%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE -2.7% ROA -2.0%

EPS

Year-to-date · US$

EPS US$-0.13

Revenue & profit

Annual · In mn (USD)

Revenue 113 mn Net income -10.9 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	64.8	71.4	74.3	85.9	93.0	103	113	106	115	130	148	156	167	120	113
Gross profit	35.2	39.0	49.0	54.5	66.6	78.9	80.4	74.3	85.8	69.0	82.9	93.6	103	76.0	63.8
Operating income	14.0	19.7	32.6	61.5	48.1	50.6	45.7	21.8	34.3	-28.3	2.62	-19.4	-87.6	-5.10	-11.1
Net income	8.47	11.8	20.6	38.3	30.8	32.5	31.8	18.7	27.2	-24.0	4.13	-14.9	-82.7	-56.4	-10.9

Balance sheet

Annual · In mn (USD)

Total assets 190 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Current assets	64.1	77.4	94.6	139	176	170	206	203	234	177	169	170	163	114	103
Total assets	133	142	156	194	236	240	283	279	331	366	348	349	271	203	190
Current liabilities	14.5	14.4	9.28	5.97	17.3	8.80	13.1	11.3	16.3	36.9	29.8	27.9	31.1	23.3	21.9
Equity	94.8	109	136	178	211	223	263	264	288	272	287	286	212	154	143

Cash flow

Annual · In mn (USD)

Operating 11.2 mn Investing -0.4 mn Financing -10.6 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating	10.2	10.6	25.2	40.0	39.1	23.8	40.8	34.9	37.0	13.1	8.40	4.41	-1.79	5.40	11.2
Investing	-1.40	-1.50	-0.25	-8.30	-30.2	-6.76	-12.5	-50.3	39.7	-71.3	-3.12	-7.49	-5.43	-8.33	-0.4
Financing	-1.17	-0.76	-5.69	5.33	1.92	-23.4	0.31	-28.9	-8.14	-3.77	-6.78	-4.85	-6.32	-12.7	-10.6
Cash at period end	35.8	44.1	63.3	100	111	104	133	89.0	157	95.8	94.4	86.3	72.9	55.6	57.5

Profitability

Annual · %

Gross margin 56.6% Operating margin -9.8% Net margin -9.6%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Gross margin	54.3%	54.7%	65.9%	63.5%	71.7%	76.3%	70.9%	70.3%	74.8%	52.9%	56.1%	59.9%	61.9%	63.4%	56.6%
Operating margin	21.6%	27.6%	43.9%	71.5%	51.8%	49.0%	40.3%	20.6%	29.9%	-21.7%	1.8%	-12.4%	-52.6%	-4.3%	-9.8%
Net margin	13.1%	16.5%	27.7%	44.6%	33.1%	31.5%	28.1%	17.7%	23.7%	-18.4%	2.8%	-9.5%	-49.6%	-47.0%	-9.6%

Returns & leverage

Annual · %

ROE -7.3% ROA -5.5%

Show table：Returns & leverage

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
ROE	8.9%	11.5%	16.8%	24.4%	15.8%	15.0%	13.1%	7.1%	9.8%	-8.6%	1.5%	-5.2%	-33.2%	-30.8%	-7.3%
ROA	6.4%	8.6%	13.8%	21.9%	14.3%	13.7%	12.2%	6.7%	8.9%	-6.9%	1.2%	-4.3%	-26.7%	-23.8%	-5.5%

EPS

Annual · US$

EPS US$-0.76

Show table：EPS

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
EPS（US$）	0.62	0.82	1.38	2.48	2.01	2.15	2.12	1.29	1.90	-1.69	0.29	-1.03	-5.65	-3.84	-0.76

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read Anika Therapeutics, Inc. (ANIK) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.